{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:30:25Z","timestamp":1762003825195,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.urolonc.2005.04.003","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T15:58:28Z","timestamp":1126108708000},"page":"318-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Inflammatory prostate cancer: An underestimated paraneoplastic clinical manifestation"],"prefix":"10.1016","volume":"23","author":[{"given":"Davide","family":"Mauri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Pentheroudakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Tolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzanna","family":"Chojnacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Pavlidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2005.04.003_bib1","series-title":"Cancer","first-page":"2511","article-title":"Paraneoplastic syndromes","author":"Arnold","year":"2001"},{"key":"10.1016\/j.urolonc.2005.04.003_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H","article-title":"Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer","volume":"41","author":"Drachenberg","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2005.04.003_bib3","first-page":"467","article-title":"High-grade inflammation in prostate cancer as a prognostic factor for biochemical recurrence after radical prostatectomy","volume":"54","author":"Irani","year":"1999","journal-title":"Pathologist Multi Center Study Group. Urology"},{"key":"10.1016\/j.urolonc.2005.04.003_bib4","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/01.ju.0000108142.53241.47","article-title":"Inflammation as a target for prostate cancer chemoprevention","volume":"171","author":"Lucia","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.04.003_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0090-4295(82)90052-8","article-title":"Fever as initial manifestation of prostatic carcinoma","volume":"19","author":"Nakamura","year":"1982","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2005.04.003_bib6","first-page":"109","article-title":"Fever as the first symptom of prostatic cancer","volume":"40","author":"Zgliczynski","year":"1985","journal-title":"Pol Tyg Lek"},{"key":"10.1016\/j.urolonc.2005.04.003_bib7","first-page":"43","article-title":"Presentation of a neoplasm of the prostate as a fever syndrome","volume":"40","author":"Hernandez Hernandez","year":"1987","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.urolonc.2005.04.003_bib8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0022-5347(05)64588-0","article-title":"The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow","volume":"168","author":"Koizumi","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2005.04.003_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.10317","article-title":"Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer","volume":"58","author":"Konig","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2005.04.003_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/(SICI)1097-0045(19990215)38:3<199::AID-PROS4>3.0.CO;2-H","article-title":"Characterization of the role of IL-6 in the progression of prostate cancer","volume":"38","author":"Chung","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2005.04.003_bib11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0090-4295(99)80034-X","article-title":"Interleukin-6","volume":"45","author":"Twillie","year":"1995","journal-title":"Urology"},{"issue":"Suppl 4","key":"10.1016\/j.urolonc.2005.04.003_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/annonc\/mdf644","article-title":"Prostate cancer: Management of advanced disease. ESMO 2002 Educational Book","volume":"13","author":"Droz","year":"2002","journal-title":"Ann Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905000761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143905000761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:51:41Z","timestamp":1761040301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143905000761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1078143905000761"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.04.003","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammatory prostate cancer: An underestimated paraneoplastic clinical manifestation","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2005.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}